CALCIUM SULFATE

CALCIUM SULFATE was reported 516 times

These side effects are most commonly reported by patients taking CALCIUM SULFATE:

# Side effect Count
0 ACUTE KIDNEY INJURY 8
1 OFF LABEL USE 8
2 HYPERTENSION 7
3 CEREBRAL HAEMORRHAGE 6
4 DRUG INEFFECTIVE 5
5 HYPERCALCAEMIA 4
6 LEUKOPENIA 4
7 PYREXIA 4
8 HEADACHE 3
9 INFLUENZA 3
10 MATERNAL EXPOSURE DURING PREGNANCY 3
11 NEUTROPENIC SEPSIS 3
12 TOXICITY TO VARIOUS AGENTS 3
13 ABDOMINAL PAIN UPPER 2
14 ANXIETY 2
15 BRONCHOSPASM 2
16 COUGH 2
17 DRUG INTERACTION 2
18 DYSPNOEA 2
19 HYPERGLYCAEMIA 2
20 HYPOPROTHROMBINAEMIA 2
21 INCORRECT DOSE ADMINISTERED 2
22 NAUSEA 2
23 OXYGEN SATURATION DECREASED 2
24 PAIN IN EXTREMITY 2
25 PANCREATITIS 2
26 PULMONARY OEDEMA 2
27 RASH 2
28 WEIGHT INCREASED 2
29 WHITE BLOOD CELL COUNT DECREASED 2
30 ABDOMINAL DISTENSION 1
31 ABDOMINAL PAIN 1
32 ADVERSE EVENT 1
33 ADVERSE REACTION 1
34 ANAPHYLACTIC REACTION 1
35 ARTHRALGIA 1
36 ASTHENIA 1
37 ASYMPTOMATIC BACTERIURIA 1
38 BACTERIURIA 1
39 BALANCE DISORDER 1
40 BLOOD BICARBONATE DECREASED 1
41 BLOOD CREATINE INCREASED 1
42 BLOOD PRESSURE FLUCTUATION 1
43 BLOOD TEST ABNORMAL 1
44 BONE PAIN 1
45 BRONCHITIS 1
46 CARDIAC DISORDER 1
47 CHILLS 1
48 CONDITION AGGRAVATED 1
49 COVID-19 1
50 CRYING 1
51 DEATH 1
52 DECREASED APPETITE 1
53 DEPRESSION 1
54 DIARRHOEA 1
55 DISCOURAGEMENT 1
56 DIZZINESS 1
57 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
58 DRUG LEVEL DECREASED 1
59 DRUG LEVEL INCREASED 1
60 DYSSTASIA 1
61 DYSURIA 1
62 EPIGASTRIC DISCOMFORT 1
63 EPILEPSY 1
64 EXCORIATION 1
65 EXPOSURE DURING PREGNANCY 1
66 FALL 1
67 FATIGUE 1
68 FEAR OF INJECTION 1
69 FEELING ABNORMAL 1
70 FLUID OVERLOAD 1
71 GAIT DISTURBANCE 1
72 GASTROINTESTINAL DISORDER 1
73 GLOSSODYNIA 1
74 HAEMATURIA 1
75 HAEMORRHOIDS 1
76 HALLUCINATION, VISUAL 1
77 HEART RATE INCREASED 1
78 HEART RATE IRREGULAR 1
79 HEPATITIS C 1
80 HERNIA 1
81 HYPERKALAEMIA 1
82 HYPOALBUMINAEMIA 1
83 HYPOCHLORAEMIA 1
84 HYPONATRAEMIA 1
85 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
86 INFLAMMATION 1
87 INJECTION SITE ERYTHEMA 1
88 INJECTION SITE PRURITUS 1
89 INJECTION SITE REACTION 1
90 INTENTIONAL PRODUCT USE ISSUE 1
91 LEFT VENTRICULAR OUTFLOW TRACT GRADIENT INCREASED 1
92 LYMPHADENOPATHY 1
93 MALAISE 1
94 MEMORY IMPAIRMENT 1
95 MYCOPLASMA INFECTION 1
96 NASOPHARYNGITIS 1
97 NEPHROPATHY TOXIC 1
98 NERVE INJURY 1
99 NEUROPATHY PERIPHERAL 1
100 NEUTROPENIA 1
101 NON-CARDIAC CHEST PAIN 1
102 NON-CARDIOGENIC PULMONARY OEDEMA 1
103 OEDEMA PERIPHERAL 1
104 ORAL MUCOSAL ERUPTION 1
105 ORCHIDECTOMY 1
106 OROPHARYNGEAL PAIN 1
107 PAIN 1
108 PANIC ATTACK 1
109 PELVIC DISCOMFORT 1
110 PLACENTAL DISORDER 1
111 PLATELET COUNT DECREASED 1
112 PNEUMONIA 1
113 POLLAKIURIA 1
114 POOR VENOUS ACCESS 1
115 PRODUCT DOSE OMISSION ISSUE 1
116 PURULENT DISCHARGE 1
117 PYURIA 1
118 RASH ERYTHEMATOUS 1
119 RASH PRURITIC 1
120 RECTAL DISCHARGE 1
121 RENAL TUBULAR NECROSIS 1
122 SINUS TACHYCARDIA 1
123 SINUSITIS 1
124 SKIN ABRASION 1
125 SOMNOLENCE 1
126 STAPHYLOCOCCAL INFECTION 1
127 STOMA SITE REACTION 1
128 SUBSTANCE ABUSE 1
129 TACHYCARDIA 1
130 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
131 THROMBOCYTOPENIA 1
132 TOOTH INFECTION 1
133 TREMOR 1
134 TUBULOINTERSTITIAL NEPHRITIS 1
135 TUMOUR LYSIS SYNDROME 1
136 TYPE 2 DIABETES MELLITUS 1
137 UNEVALUABLE EVENT 1
138 URINE KETONE BODY PRESENT 1
139 URINE OUTPUT DECREASED 1
140 VOMITING 1
141 WEIGHT DECREASED 1
142 WHITE BLOOD CELL COUNT INCREASED 1